José Pontes‐Júnior

640 total citations
24 papers, 482 citations indexed

About

José Pontes‐Júnior is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, José Pontes‐Júnior has authored 24 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in José Pontes‐Júnior's work include Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Protease and Inhibitor Mechanisms (4 papers). José Pontes‐Júnior is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Protease and Inhibitor Mechanisms (4 papers). José Pontes‐Júnior collaborates with scholars based in Brazil and India. José Pontes‐Júnior's co-authors include Miguel Srougi, Kátia Ramos Moreira Leite, Sabrina T. Reis, Marcos F. Dall’Oglio, Nayara Izabel Viana, Alberto A. Antunes, Alexandre Crippa, Denis R. Morais, Nelson Dip and Carlo C. Passerotti and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The FASEB Journal.

In The Last Decade

José Pontes‐Júnior

21 papers receiving 478 citations

Peers

José Pontes‐Júnior
Deborah L. Cundiff United States
José Pontes‐Júnior
Citations per year, relative to José Pontes‐Júnior José Pontes‐Júnior (= 1×) peers Deborah L. Cundiff

Countries citing papers authored by José Pontes‐Júnior

Since Specialization
Citations

This map shows the geographic impact of José Pontes‐Júnior's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Pontes‐Júnior with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Pontes‐Júnior more than expected).

Fields of papers citing papers by José Pontes‐Júnior

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Pontes‐Júnior. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Pontes‐Júnior. The network helps show where José Pontes‐Júnior may publish in the future.

Co-authorship network of co-authors of José Pontes‐Júnior

This figure shows the co-authorship network connecting the top 25 collaborators of José Pontes‐Júnior. A scholar is included among the top collaborators of José Pontes‐Júnior based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Pontes‐Júnior. José Pontes‐Júnior is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leite, Kátia Ramos Moreira, Leonardo Cardili, Evandro Sobroza de Mello, et al.. (2024). ERG and PTEN Role on Active Surveillance for Low‐Risk Prostate Cancer in the Multiparametric MRI Era. The Prostate. 85(4). 364–373. 1 indexed citations
2.
Leite, Kátia Ramos Moreira, et al.. (2021). High CD39 expression is associated with the non-muscle-invasive phenotype of human bladder cancer. Oncotarget. 12(16). 1580–1586. 7 indexed citations
3.
Dellê, Humberto, Cleber Camacho, Sabrina T. Reis, et al.. (2020). Indoleamine 2,3-dioxygenase expression in the prognosis of the localized prostate cancer. International Urology and Nephrology. 52(8). 1477–1482. 7 indexed citations
4.
Viana, Nayara Izabel, Denis R. Morais, Caio M. Moura, et al.. (2018). miR-618: possible control over TIMP-1 and its expression in localized prostate cancer. BMC Cancer. 18(1). 992–992. 7 indexed citations
5.
Viana, Nayara Izabel, Denis R. Morais, Iran A. Silva, et al.. (2018). miR-29b enhances prostate cancer cell invasion independently of MMP-2 expression. Cancer Cell International. 18(1). 18–18. 24 indexed citations
7.
Pontes‐Júnior, José, Sabrina T. Reis, Humberto Dellê, et al.. (2017). Correlation between Chromosome 9p21 Locus Deletion and Prognosis in Clinically Localized Prostate Cancer. The International Journal of Biological Markers. 32(2). 248–254. 4 indexed citations
8.
Reis, Sabrina T., Nayara Izabel Viana, Kátia Ramos Moreira Leite, et al.. (2016). Role of Genetic Polymorphisms in the Development and Prognosis of Sporadic and Familial Prostate Cancer. PLoS ONE. 11(12). e0166380–e0166380. 4 indexed citations
9.
Giannella‐Neto, Daniel, et al.. (2016). The Role of Indoleamine 2,3‐Dioxygenase (IDO) on PC‐3 Prostate Cancer Cells Viability. The FASEB Journal. 30(S1).
10.
Cordeiro, Maurício, Rafael F. Coelho, Daher C. Chade, et al.. (2014). A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients. British Journal of Urology. 117(2). 266–271. 42 indexed citations
11.
Pontes‐Júnior, José, Sabrina T. Reis, Nayara Izabel Viana, et al.. (2013). Adhesion molecules of detrusor muscle cells are influenced by a hypercholesterolemic diet or bladder outlet obstruction in a wistar rat model. BMC Urology. 13(1). 50–50. 2 indexed citations
12.
Reis, Sabrina T., José Pontes‐Júnior, Nayara Izabel Viana, et al.. (2013). The role of micro RNAs let7c, 100 and 218 expression and their target RAS, C-MYC, BUB1, RB, SMARCA5, LAMB3 and Ki-67 in prostate cancer. Clinics. 68(5). 652–657. 28 indexed citations
13.
Pontes‐Júnior, José, Sabrina T. Reis, Marcos F. Dall’Oglio, et al.. (2013). Correlation between Beta1 integrin expression and prognosis in clinically localized prostate cancer. International braz j urol. 39(3). 335–343. 13 indexed citations
14.
Leite, Kátia Ramos Moreira, et al.. (2013). Carbonic Anhydrase IX is Not a Predictor of Outcomes in Non-Metastatic Clear Cell Renal Cell Carcinoma - A Digital Analysis of Tissue Microarray. International braz j urol. 39(4). 484–492. 8 indexed citations
15.
Reis, Sabrina T., Kátia Ramos Moreira Leite, José Pontes‐Júnior, et al.. (2012). Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer. BMC Urology. 12(1). 18–18. 103 indexed citations
16.
Reis, Sabrina T., José Pontes‐Júnior, Alberto A. Antunes, et al.. (2012). miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer. BMC Urology. 12(1). 14–14. 102 indexed citations
17.
Reis, Sabrina T., Alberto A. Antunes, José Pontes‐Júnior, et al.. (2012). Underexpression of MMP-2 and its regulators, TIMP2, MT1-MMP and IL-8, is associated with prostate cancer. International braz j urol. 38(2). 167–174. 17 indexed citations
18.
Dall’Oglio, Marcos F., Alexandre Crippa, José Pontes‐Júnior, et al.. (2010). The beginning of the 21st century: a paradigm shift in the surgical management of renal cell carcinoma in South America. International braz j urol. 36(6). 670–677.
19.
Pontes‐Júnior, José, Sabrina T. Reis, Marcos F. Dall’Oglio, et al.. (2010). Association between integrin expression and prognosis in localized prostate cancer. The Prostate. 70(11). 1189–1195. 29 indexed citations
20.
Pontes‐Júnior, José, Sabrina T. Reis, Marcos F. Dall’Oglio, et al.. (2009). Evaluation of the expression of integrins and cell adhesion molecules through tissue microarray in lymph node metastases of prostate cancer. Journal of Carcinogenesis. 8(1). 3–3. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026